The Spot The Early Signs program aims to fight under-diagnosed or late-diagnosed conditions for which treatments are available and where early detection and early treatment could make a significant difference in the condition's development, the quality of life and the survival of patients. 

Alpha-mannosidosis is an ultra-rare genetic disorder caused by a deficiency of the lysosomal enzyme alpha-mannosidase. The symptoms, severity, and progression of alpha-mannosidosis vary widely between individuals, making diagnosis challenging and often delayed. Minimizing the time to diagnosis is important in ensuring that individuals with alpha-mannosidosis and their families receive timely access to support and specialist MDT care.

To assist, EIP has launched the Spot the Early Signs Resource Centre to spread education in local medical communities and further develop and expand the trained frontline healthcare professionals network. The Resource Centre allows members to collaborate, engage and interact and where they can easily find information and education when needed - both for members and to share with colleagues. All recorded webinars are available to view without charge via the Resources Section of the site, along with further information on the Faculty, the Upcoming Live New Webinars and how you can Join Us to make your colleagues ‘think rare’ at every opportunity.